1 not yet recruiting, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Dren Bio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes Dibotatug (DR-01) - Bone Marrow Failure Syndromes, Aplastic Anemias | Phase 1 / Phase 2 | Not yet recruiting | Dren Bio | 60 | 2026-08-01 | 2026-07-24 |
| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas DR-01 - LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma | Phase 1 / Phase 2 | Recruiting | Dren Bio | 200 | 2022-07-13 | 2026-06-17 |
Anemia, Aplastic (1) · Bone Marrow Failure Disorders (1) · Enteropathy-Associated T-Cell Lymphoma (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Large Granular Lymphocytic (1) · Leukocyte Disorders (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Pancytopenia (1) · Recurrence (1) · Subcutaneous panniculitis-like T-cell lymphoma (1)
United States (2) · Australia (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · South Korea (1) · Spain (1) · Taiwan (1)
Wan-Jen Hong, MD (2)